Painless Multiple Cranial Neuropathies due to Symptomatic Bone Marrow Metastasis in First Diagnosis of Advanced Stage Breast Cancer: A Case Report

Siriporn Lin, Jarukit Tantipisit, Nattha Sanghan, Pat Korathanakhun

Abstract

Metastatic breast cancer commonly involves the bone, liver, and lungs. While bone marrow metastasis (BMM) is rare, it has a significant association with distant recurrence and diminished survival rates. Typically, BMM manifests with hematological abnormalities and none of the previous reports revealed BMM as a first presentation in breast cancer patients. Herein is a reported case of painless, multiple cranial neuropathies as an unusual initial manifestation of symptomatic BMM, marking the first presentation of metastatic breast cancer.

 

 Keywords

advanced-stage breast cancer; bone marrow metastasis; cranial neuropathies

 Full Text:

PDF

References

GLOBOCAN 2020 cancer incidence and mortality worldwide [homepage on the Internet]. Lyon: France; IARC CancerBase; 2020 [cited 2024 Apr 9]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf.

Kopp HG, Krauss K, Fehm T, Staebler A, Zahm J, Vogel W, et al. Symptomatic bone marrow involvement in breast cancer-clinical presentation, treatment and prognosis: a single institution review of 22 cases. Anticancer Res 2011;31:4025–30.

Widick P, Brunner AM, Schiffman F. Hematologic manifestations of malignancy. In: Hoffman R, Silberstein LE, Weitz JI, Salama ME, Benz EJ, Heslop HE, Anastasi J, Abutalib SA, editors. Hematology. 7th ed. Philadelphia: Elsevier; 2018; 2247-52.

Xiao L, Luxi S, Ying T, Yizhi L, Lingyun W, Quan P. Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol 2008;135:687–93.

Coombes RC, Powles TJ, Abbott M, L De Rivas, Ford HT, McCready VR, et al. Physical test for distant metastases in patients with breast cancer. J R Soc Med 1980;73:617–23.

Kamby C, Guldhammer B, Vejborg I, Rossing N, Dirksen H, Daugaard S, et al. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 1987;60:1306–12.

Distefano A, Tashima CK, Yap HY, Hortobagyi GN. Bone marrow metastases without cortical bone involvement in breast cancer patients. Cancer 1979;44:196–8.

Landys K. Prognostic value of bone marrow biopsy in breast cancer. Cancer 1982;49:513–8.

Yang R, Jia L, Lu G, Zheng Lv, Cui J. Symptomatic bone marrow metastases in breast cancer: a retrospective cohort study. Front Oncol 2022;12:1042773.

Demir L, Akyol M, Bener S, Payzin KB, Erten C, Somali I, et al. Prognostic evaluation of breast cancer patients with evident bone marrow metastasis. Breast J 2014;20:279–87.

Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Yuen S, et al. Metastatic skull tumors: MRI features and a new conventional classification. J Neurooncol 2010;104:239–45.

Sanal SM, Flickinger FW, Caudell MJ, Sherry RM. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging. J Clin Oncol 1994;12:1415–21.

Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353:793–802.

Wieder R. Awakening of dormant breast cancer cells in the bone marrow. Cancers (Basel) 2023;15.

Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. Lancet Oncol 2020;21:519–30.

DOI: http://dx.doi.org/10.31584/jhsmr.20241121

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.